Eli Lilly LLY Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Eli Lilly's financing cash flow?
- Eli Lilly (LLY) reported financing cash flow of -$3.47B in Q1 2026.
- How has Eli Lilly's financing cash flow changed year-over-year?
- Eli Lilly's financing cash flow decreased by 351.4% year-over-year, from $1.38B to -$3.47B.
- What is the long-term trend for Eli Lilly's financing cash flow?
- Over 3 years (2021 to 2025), Eli Lilly's financing cash flow has grown at a -18.8% compound annual growth rate (CAGR), from -$4.13B to -$2.21B.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.